We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

95 hedge funds and large institutions have $123M invested in Cytokinetics in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $2.99M | Put options by funds: $1M

18% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 28

6% less funds holding

Funds holding: 101 → 95 (-6)

13% less capital invested

Capital invested by funds: $141M → $123M (-$17.7M)

26% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 23

Holders
95
Holders Change
-6
Holders Change %
-5.94%
% of All Funds
2.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
33
Reduced
28
Closed
23
Calls
$2.99M
Puts
$1M
Net Calls
+$1.99M
Net Calls Change
-$1.49M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$4.27M
2
TC
TFS Capital
Pennsylvania
+$2.99M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.2M
4
BA
BlackRock Advisors
Delaware
+$1.77M
5
Deutsche Bank
Deutsche Bank
Germany
+$983K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$10.9M
2
BIM
Bogle Investment Management
Massachusetts
-$3.38M
3
Millennium Management
Millennium Management
New York
-$2.05M
4
Morgan Stanley
Morgan Stanley
New York
-$802K
5
GACM
Green Arrow Capital Management
New York
-$757K
Name Holding Trade Value Shares
Change 		Change in
Stake
MLICM
101
Metropolitan Life Insurance Company (MetLife)
New York
– -$156K -20,612 Closed
TD Asset Management
102
TD Asset Management
Ontario, Canada
– -$143K -18,868 Closed
GT
103
Glenmede Trust
Pennsylvania
– -$138K -17,905 Closed
ProShare Advisors
104
ProShare Advisors
Maryland
– -$128K -16,842 Closed
SCA
105
SAC Capital Advisors
Connecticut
– -$117K -15,403 Closed
EWM
106
Evercore Wealth Management
New York
– -$113K -14,914 Closed
Bank of Montreal
107
Bank of Montreal
Ontario, Canada
– -$92K -12,100 Closed
SO
108
STRS Ohio
Ohio
– -$84K -11,100 Closed
Invesco
109
Invesco
Georgia
– -$83K -10,998 Closed
Goldman Sachs
110
Goldman Sachs
New York
– -$80K -10,583 Closed
HIM
111
Hillsdale Investment Management
Ontario, Canada
– -$47K -6,200 Closed
Ameriprise
112
Ameriprise
Minnesota
– -$13K -1,654 Closed
RFC
113
Russell Frank Company
Washington
– -$12K -1,545 Closed
Acadian Asset Management
114
Acadian Asset Management
Massachusetts
– -$8K -1,118 Closed
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
– -$3K -358 Closed
FHA
116
First Horizon Advisors
Tennessee
– +$13 +2 New
MFS
117
MSI Financial Services
Massachusetts
– +$13 +2 New
1 2 3 4
5

CYTK Hedge Fund Activity: Q4 2013 in Review

95 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2013, worth a combined $123M — down 13% from $141M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CYTK and 17 opened new positions — a net loss of 6 holders — while 28 trimmed existing stakes and 33 added.

The largest buyer was BVF Inc, adding an estimated $4.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $10.9M sold.

  • 95 institutional investors held Cytokinetics (CYTK) as of Q4 2013, down from 101 in Q3 2013.
  • Funds reported $123M of Cytokinetics stock for Q4 2013, down 13% quarter-over-quarter.
  • 17 funds opened new Cytokinetics positions in Q4 2013 and 23 closed out, a net change of -6 holders.
  • The largest Cytokinetics buyer in Q4 2013 was BVF Inc, an estimated $4.27M added.
  • The largest Cytokinetics seller in Q4 2013 was T. Rowe Price Associates, an estimated $10.9M sold.

Based on aggregated 13F filings for Q4 2013.